Total Payments
$2,117
2023 Payments
$79.35
Companies
14
Transactions
95
Medicare Patients
5,243
Medicare Billing
$478,452
Payment Breakdown by Category
Food & Beverage$1,640 (77.5%)
Education$477.29 (22.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,640 | 90 | 77.5% |
| Education | $477.29 | 5 | 22.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $967.16 | 39 | $0 (2023) |
| AbbVie Inc. | $403.07 | 27 | $0 (2021) |
| PFIZER INC. | $153.27 | 11 | $0 (2021) |
| Allergan Inc. | $145.77 | 2 | $0 (2019) |
| UROVANT SCIENCES INC | $119.13 | 2 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $111.99 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $67.16 | 3 | $0 (2019) |
| Avadel Specialty Pharmaceuticals, LLC | $39.98 | 3 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $29.43 | 2 | $0 (2018) |
| SI-BONE, INC. | $23.43 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $79.35 | 1 | Astellas Pharma US Inc ($79.35) |
| 2021 | $582.64 | 30 | AbbVie Inc. ($191.49) |
| 2020 | $199.83 | 8 | Astellas Pharma US Inc ($170.99) |
| 2019 | $406.88 | 15 | Astellas Pharma US Inc ($182.24) |
| 2018 | $422.69 | 24 | Astellas Pharma US Inc ($240.98) |
| 2017 | $425.90 | 17 | Astellas Pharma US Inc ($140.18) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 4 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2018 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: UROLOGY | ||||||
| 01/24/2018 | AbbVie, Inc. | Androgel (Drug), Lupron | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Endocrinology | ||||||
| 01/15/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug), XTANDI, VESICARE | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: UROLOGY | ||||||
| 11/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Urology | ||||||
| 10/25/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Urology | ||||||
| 09/14/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: Urology | ||||||
| 09/11/2017 | AbbVie, Inc. | Androgel (Drug), Lupron | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Endocrinology | ||||||
| 08/15/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Endocrinology | ||||||
| 07/19/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Endocrinology | ||||||
| 06/29/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $111.99 | General |
| Category: PDP | ||||||
| 04/25/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Urology | ||||||
| 04/18/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Endocrinology | ||||||
| 03/15/2017 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, ZURAMPIC | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Gastroenterology | ||||||
| 03/07/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Urology | ||||||
| 02/15/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: Oncology | ||||||
| 02/15/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 02/07/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Urology | ||||||
| 01/31/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 01/11/2017 | AbbVie, Inc. | Androgel (Drug), Lupron | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Endocrinology | ||||||
| 01/10/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 18 | 2,652 | 5,007 | $375,127 | $247,188 |
| 2020 | 19 | 2,591 | 4,800 | $328,069 | $231,264 |
Total Patients
5,243
Total Services
9,807
Medicare Billing
$478,452
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 456 | 857 | $125,229 | $89,523 | 71.5% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2021 | 479 | 784 | $63,864 | $38,651 | 60.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 19 | 194 | $40,554 | $27,526 | 67.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 170 | 325 | $33,547 | $25,875 | 77.1% |
| 52281 | Dilation of bladder canal (urethra) using an endoscope | Office | 2021 | 68 | 86 | $39,445 | $25,763 | 65.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 67 | 67 | $14,673 | $9,442 | 64.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 130 | $12,307 | $7,485 | 60.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 483 | 984 | $6,077 | $5,092 | 83.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 487 | 989 | $4,781 | $3,961 | 82.8% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 13 | 13 | $4,476 | $2,817 | 62.9% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 17 | 22 | $16,196 | $2,604 | 16.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 116 | 228 | $3,359 | $2,156 | 64.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $3,249 | $1,960 | 60.3% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 13 | 13 | $2,641 | $1,691 | 64.0% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 19 | 41 | $1,896 | $1,085 | 57.2% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 13 | 13 | $1,018 | $683.02 | 67.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 154 | 213 | $757.56 | $639.00 | 84.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2021 | 20 | 30 | $1,059 | $235.20 | 22.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 452 | 893 | $109,699 | $78,669 | 71.7% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2020 | 462 | 673 | $47,085 | $30,779 | 65.4% |
| 52281 | Dilation of bladder canal (urethra) using an endoscope | Office | 2020 | 71 | 96 | $36,189 | $27,444 | 75.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 13 | 126 | $29,466 | $22,523 | 76.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 194 | $16,480 | $12,752 | 77.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 124 | $14,370 | $11,083 | 77.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 82 | 82 | $15,146 | $10,899 | 72.0% |
About Dr. Sidney Goldfarb, MD
Dr. Sidney Goldfarb, MD is a Urology healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093776916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sidney Goldfarb, MD has received a total of $2,117 in payments from pharmaceutical and medical device companies, with $79.35 received in 2023. These payments were reported across 95 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,640).
As a Medicare-enrolled provider, Goldfarb has provided services to 5,243 Medicare beneficiaries, totaling 9,807 services with total Medicare billing of $478,452. Data is available for 2 years (2020–2021), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Princeton, NJ
- Active Since 03/30/2006
- Last Updated 10/05/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093776916
Products in Payments
- XTANDI (Drug) $288.75
- LUPRON DEPOT (Drug) $204.51
- MYRBETRIQ (Drug) $172.97
- BOTOX (Drug) $125.01
- Myrbetriq (Drug) $121.82
- GEMTESA (Drug) $119.13
- NUPLAZID (Drug) $111.99
- Androgel (Drug) $105.48
- Lupron Depot (Drug) $43.93
- Noctiva (Drug) $39.98
- ZYTIGA (Drug) $39.57
- Lupron (Drug) $33.33
- Erleada (Drug) $27.59
- TOVIAZ (Drug) $26.92
- IFUSE IMPLANT (Device) $23.43
- BOTOX OAB (Drug) $20.76
- Xtandi (Drug) $18.36
- LINZESS (Drug) $16.84
- NOCDURNA (Drug) $15.38
- VESICARE (Drug) $14.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Princeton
Dr. Alexander Vukasin, M.d, M.D
Urology — Payments: $6,260
Urology $6,260
Dr. Alexei Wedmid, Md, MD
Urology — Payments: $3,313
Urology $3,313
Dr. Barry Rossman, M.d, M.D
Urology — Payments: $3,134
Urology $3,134
Karen Latzko, D.o, D.O
Urology — Payments: $2,024
Urology $2,024
Naeem Pervaiz, Md, MD
Urology — Payments: $868.81
Urology $868.81
Marc Schwarzman, M.d, M.D
Urology — Payments: $570.85
Urology $570.85